Background: The relatively common co-occurrence of type 1 diabetes (T1D) and celiac disease (CD) suggests these disorders share common pathogenic etiologies. Summary: T1D and CD are strongly linked to closely related high-risk human lymphocyte antigens (HLA-DR-DQ). High-risk HLA molecules bind specific fragments of gluten or the islet self-antigen(s) and present these antigens to antigen-responsive T cells. In an appropriate proinflammatory environment, the autoimmune response results in destruction of the intestinal enterocyte and/or the pancreatic beta cell. Environmental factors have been implicated in the etiology of T1D and CD because (1) identical twins are only partially concordant for these disorders and (2) incidence rates of T1D and CD have been steadily rising for decades. Prospective studies in infants genetically predisposed to T1D and CD showed that antibody positivity to both disorders begins in the first 1–3 years of life. Viral infections and early exposure to gluten or cow’s milk in the infant diet have been implicated in disease pathogenesis. However, delaying introduction of gluten in the infant diet until 12 months of age had no impact on the development of islet or celiac autoimmunity. Weaning nursing infants to hydrolyzed infant formula had no impact on the development of T1D. Viral infections have been suspected of playing a role in T1D pathogenesis for decades. A large international prospective study (TEDDY) has shown increased risk of T1D autoimmunity particularly when >5 respiratory infections or febrile infections have occurred in the 9 months preceding the appearance of islet antibodies. Provocative data in animal models of T1D suggest the microbiome may play an important role in the pathogenesis of T1D. Breastfeeding, diet, infections, antibiotics, and method of birth alter the composition of the microbiome. Human data indicate subtle differences in the microbiome of children with T1D autoimmunity, while intestinal dysbiosis has been clearly demonstrated in CD. Alterations of the integrity of the intestinal mucosa plays an important role in the pathogenesis of CD, and the NOD mouse model suggests an important role of a leaky intestinal epithelium in T1D as well. Key Message: Immunogenetics and the environment are closely interrelated in the pathogenesis of T1D and CD. Large well-designed prospective studies in at-risk populations informed by scientifically rigorous studies in animal models are likely to have the greatest impact on our understanding of the complex pathogenesis of these detrimental autoimmune disorders.

1.
Pham-Short
A
,
Donaghue
KC
,
Ambler
G
,
Phelan
H
,
Twigg
S
,
Craig
ME
.
Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review
.
Pediatrics
.
2015
Jul
;
136
(
1
):
e170
6
.
[PubMed]
0031-4005
2.
Hagopian
W
,
Lee
HS
,
Liu
E
,
Rewers
M
,
She
JX
,
Ziegler
A.
, . . .
Agardh
D
(
2017
). Co-occurrence of Type 1 Diabetes and Celiac Disease Autoimmunity. Pediatrics 2017; 140(5)
3.
Kaur
N
,
Bhadada
SK
,
Minz
RW
,
Dayal
D
,
Kochhar
R
.
Interplay between Type 1 Diabetes Mellitus and Celiac Disease: implications in Treatment
.
Dig Dis
.
2018
;
36
(
6
):
399
408
.
[PubMed]
0257-2753
4.
Ludvigsson
JF
,
Biagi
F
,
Corazza
GR
.
Epidemiology of Celiac Disease.
Rampertab, S., & Mullin, G. (
2014
). Celiac Disease. New York: Humana Press.
5.
Children and Adolescents
.
12. Children and Adolescents: Standards of Medical Care in Diabetes—2018
.
Diabetes Care
.
2018
;
41
Supplement 1
:
S126
36
.
[PubMed]
0149-5992
6.
Mahmud
FH
,
Elbarbary
NS
,
Fröhlich-Reiterer
E
,
Holl
RW
,
Kordonouri
O
,
Knip
M
, et al.
ISPAD Clinical Practice Consensus Guidelines 2018: other complications and associated conditions in children and adolescents with type 1 diabetes
.
Pediatr Diabetes
.
2018
Oct
;
19
Suppl 27
:
275
86
.
[PubMed]
1399-543X
7.
Tavakkoli
A
,
Lebwohl
B
. Diagnosis of Celiac Disease. In: Rampertab, S., & Mullin, G. (
2014
). Celiac Disease. New York: Humana Press.
8.
Snyder
J
,
Butzner
JD
,
DeFelice
AR
,
Fasano
A
,
Guandalini
S
,
Liu
E
, et al.
Evidence-Informed Expert Recommendations for the Management of Celiac Disease in Children
.
Pediatrics
.
2016
Sep
;
138
(
3
):
1
.
[PubMed]
0031-4005
9.
Schiepatti
A
,
Sanders
DS
,
Biagi
F
.
Seronegative coeliac disease: clearing the diagnostic dilemma
.
Curr Opin Gastroenterol
.
2018
May
;
34
(
3
):
154
8
.
[PubMed]
0267-1379
10.
Ludvigsson
JF
,
Neovius
M
,
Hammarström
L
.
Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study
.
J Clin Immunol
.
2014
May
;
34
(
4
):
444
51
.
[PubMed]
0271-9142
11.
Husby
S
,
Koletzko
S
,
Korponay-Szabó
IR
,
Mearin
ML
,
Phillips
A
,
Shamir
R
, et al.;
ESPGHAN Working Group on Coeliac Disease Diagnosis
;
ESPGHAN Gastroenterology Committee
;
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
.
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease
.
J Pediatr Gastroenterol Nutr
.
2012
Jan
;
54
(
1
):
136
60
.
[PubMed]
0277-2116
12.
Bibbins-Domingo
K
,
Grossman
DC
,
Curry
SJ
,
Barry
MJ
,
Davidson
KW
,
Doubeni
CA
, et al.;
US Preventive Services Task Force
.
Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement
.
JAMA
.
2017
Mar
;
317
(
12
):
1252
7
.
[PubMed]
0098-7484
13.
Simmons
KM
,
McFann
K
,
Taki
I
,
Liu
E
,
Klingensmith
GJ
,
Rewers
MJ
, et al.
Reduced Bone Mineral Density Is Associated with Celiac Disease Autoimmunity in Children with Type 1 Diabetes
.
J Pediatr
.
2016
Feb
;
169
:
44
8.e1
.
[PubMed]
0022-3476
14.
Fröhlich-Reiterer
EE
,
Kaspers
S
,
Hofer
S
,
Schober
E
,
Kordonouri
O
,
Pozza
SB
, et al.;
Diabetes Patienten Verlaufsdokumentationssystem-Wiss Study Group
.
Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease
.
J Pediatr
.
2011
Apr
;
158
(
4
):
589
593.e2
.
[PubMed]
0022-3476
15.
Herman
ML
,
Absah
I
,
Oxentenko
AS
,
Rubio-Tapia
A
. Monitoring and Follow-Up of patients with celiac disease. In: Rampertab,S & Mullin, G. (
2014
). Celiac Disease. New York: Humana Press.
16.
Simpson
S
,
Thompson
T
;
Nutrition in Celiac Disease
. In: Rampertab, S., & Mullin, G. (
2014
). Celiac Disease. New York: Humana Press.
17.
Leonard
MM
,
Weir
DC
,
DeGroote
M
,
Mitchell
PD
,
Singh
P
,
Silvester
JA
, et al.
Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet
.
J Pediatr Gastroenterol Nutr
.
2017
Feb
;
64
(
2
):
286
91
.
[PubMed]
0277-2116
18.
Simmons
JH
,
Foster
NC
,
Riddlesworth
TD
,
DuBose
SN
,
Redondo
MJ
,
Liu
E
, et al.;
T1D Exchange Clinic Network
.
Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry
.
Pediatr Diabetes
.
2018
Jun
;
19
(
4
):
741
8
.
[PubMed]
1399-543X
19.
Pham-Short
A
,
Donaghue
KC
,
Ambler
G
,
Garnett
S
,
Craig
ME
.
Greater postprandial glucose excursions and inadequate nutrient intake in youth with type 1 diabetes and celiac disease
.
Sci Rep
.
2017
Mar
;
7
(
1
):
45286
.
[PubMed]
2045-2322
20.
Leeds
JS
,
Hopper
AD
,
Hadjivassiliou
M
,
Tesfaye
S
,
Sanders
DS
.
High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease
.
Diabetes Care
.
2011
Oct
;
34
(
10
):
2158
63
.
[PubMed]
0149-5992
21.
Rohrer
TR
,
Wolf
J
,
Liptay
S
,
Zimmer
KP
,
Fröhlich-Reiterer
E
,
Scheuing
N
, et al.;
DPV Initiative and the German BMBF Competence Network Diabetes Mellitus
.
Microvascular Complications in Childhood-Onset Type 1 Diabetes and Celiac Disease: A Multicenter Longitudinal Analysis of 56,514 Patients From the German-Austrian DPV Database
.
Diabetes Care
.
2015
May
;
38
(
5
):
801
7
.
[PubMed]
0149-5992
22.
Mollazadegan
K
,
Kugelberg
M
,
Montgomery
SM
,
Sanders
DS
,
Ludvigsson
J
,
Ludvigsson
JF
.
A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease
.
Diabetes Care
.
2013
Feb
;
36
(
2
):
316
21
.
[PubMed]
0149-5992
23.
Pham-Short
A
,
C Donaghue
K
,
Ambler
G
,
K Chan
A
,
Hing
S
,
Cusumano
J
, et al.
Early elevation of albumin excretion rate is associated with poor gluten-free diet adherence in young people with coeliac disease and diabetes
.
Diabet Med
.
2014
Feb
;
31
(
2
):
208
12
.
[PubMed]
0742-3071
24.
Delli
AJ
,
Lernmark
A
. Type 1 (Insulin-Dependent) Diabetes Mellitus: Etiology, Pathogenesis, Prediction, and Prevention. In: Endocrinology: Adult and Pediatric. 7 th ed
2016
, Saunders Chapter 39:672
25.
Noble
JA
.
Immunogenetics of type 1 diabetes: A comprehensive review
.
J Autoimmun
.
2015
Nov
;
64
:
101
12
.
[PubMed]
0896-8411
26.
Elliott
DE
. The Pathophysiology of Celiac Disease. In: Rampertab, S., & Mullin, G. (
2014
). Celiac Disease. New York: Humana Press. Chapter 4.
27.
De Haas
EC
,
Kumar
V
,
Wijmenga
C
. Immunogenetics of Celiac Disease. In: Rampertab, S., & Mullin, G. (
2014
). Celiac Disease. New York: Humana Press.Chapter 5
28.
Kent
SC
,
Chen
Y
,
Bregoli
L
,
Clemmings
SM
,
Kenyon
NS
,
Ricordi
C
, et al.
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope
.
Nature
.
2005
May
;
435
(
7039
):
224
8
.
[PubMed]
0028-0836
29.
Turley
SJ
,
Lee
JW
,
Dutton-Swain
N
,
Mathis
D
,
Benoist
C
.
Endocrine self and gut non-self intersect in the pancreatic lymph nodes
.
Proc Natl Acad Sci USA
.
2005
Dec
;
102
(
49
):
17729
33
.
[PubMed]
0027-8424
30.
Lundgren
M
,
Steed
LJ
,
Tamura
R
,
Jonsdottir
B
,
Gesualdo
P
,
Crouch
C
, et al.;
TEDDY Study Group
.
Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity
.
BMC Pediatr
.
2017
May
;
17
(
1
):
127
.
[PubMed]
1471-2431
31.
Yeung
WC
,
Rawlinson
WD
,
Craig
ME
.
Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies
.
BMJ
.
2011
Feb
;
342
(
7794
):
d35
.
[PubMed]
0959-8138
32.
Krogvold
L
,
Edwin
B
,
Buanes
T
,
Frisk
G
,
Skog
O
,
Anagandula
M
, et al.
Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes
.
Diabetes
.
2015
May
;
64
(
5
):
1682
7
.
[PubMed]
0012-1797
33.
Lönnrot
M
,
Lynch
KF
,
Elding Larsson
H
,
Lernmark
Å
,
Rewers
MJ
,
Törn
C
, et al.;
TEDDY Study Group
.
Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study
.
Diabetologia
.
2017
Oct
;
60
(
10
):
1931
40
.
[PubMed]
0012-186X
34.
Knip
M
,
Åkerblom
HK
,
Al Taji
E
,
Becker
D
,
Bruining
J
,
Castano
L
, et al.;
Writing Group for the TRIGR Study Group
.
Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial
.
JAMA
.
2018
Jan
;
319
(
1
):
38
48
.
[PubMed]
0098-7484
35.
Hummel
S
,
Pflüger
M
,
Hummel
M
,
Bonifacio
E
,
Ziegler
AG
.
Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study
.
Diabetes Care
.
2011
Jun
;
34
(
6
):
1301
5
.
[PubMed]
0149-5992
36.
Beyerlein
A
,
Chmiel
R
,
Hummel
S
,
Winkler
C
,
Bonifacio
E
,
Ziegler
AG
.
Timing of gluten introduction and islet autoimmunity in young children: updated results from the BABYDIET study
.
Diabetes Care
.
2014
Sep
;
37
(
9
):
e194
5
.
[PubMed]
0149-5992
37.
Lund-Blix
NA
,
Dong
F
,
Mårild
K
,
Seifert
J
,
Barón
AE
,
Waugh
KC
, et al.
Guten Intake and risk of autoimmunity and progression to type 1diabetes in children at increased risk of the disease: The Diabetes Autoimmunity Study in the Young (DAISY)
.
Diabetes Care
.
2019
May
;
42
(
5
):
789
96
.
[PubMed]
0149-5992
38.
Lynch
SV
,
Pedersen
O
.
The Human Intestinal Microbiome in Health and Disease
.
N Engl J Med
.
2016
Dec
;
375
(
24
):
2369
79
.
[PubMed]
0028-4793
39.
Paun
A
,
Yau
C
,
Danska
JS
.
The Influence of the Microbiome on Type 1 Diabetes
.
J Immunol
.
2017
Jan
;
198
(
2
):
590
5
.
[PubMed]
0022-1767
40.
Wen
L
,
Ley
RE
,
Volchkov
PY
,
Stranges
PB
,
Avanesyan
L
,
Stonebraker
AC
, et al.
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
.
Nature
.
2008
Oct
;
455
(
7216
):
1109
13
.
[PubMed]
0028-0836
41.
Silverman
M
,
Kua
L
,
Tanca
A
,
Pala
M
,
Palomba
A
,
Tanes
C
, et al.
Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny
.
Proc Natl Acad Sci USA
.
2017
Sep
;
114
(
36
):
9671
6
.
[PubMed]
0027-8424
42.
Kostic
G
,
Siljander
V
,
Hyötyläinen
H
, et al.
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
.
Cell Host Microbe
.
2016
;
20
(
1
):
121
.
[PubMed]
1931-3128
43.
Stewart
CJ
,
Ajami
NJ
,
O’Brien
JL
,
Hutchinson
DS
,
Smith
DP
,
Wong
MC
, et al.
Temporal development of the gut microbiome in early childhood from the TEDDY study
.
Nature
.
2018
Oct
;
562
(
7728
):
583
8
.
[PubMed]
0028-0836
44.
Vatanen
T
,
Franzosa
EA
,
Schwager
R
,
Tripathi
S
,
Arthur
TD
,
Vehik
K
, et al.
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
.
Nature
.
2018
Oct
;
562
(
7728
):
589
94
.
[PubMed]
0028-0836
45.
Uusitalo
U
,
Liu
X
,
Yang
J
,
Aronsson
CA
,
Hummel
S
,
Butterworth
M
, et al.;
TEDDY Study Group
.
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
.
JAMA Pediatr
.
2016
Jan
;
170
(
1
):
20
8
.
[PubMed]
2168-6203
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.